Your office's limit isn't ideas. It's how many it can assess.
Disclosures and publications grow with your research budget. The staff and counsel who assess them do not. So potentially protectable inventions go unscreened. Yet federal funders still expect you to identify them. Patenter gives every disclosure and paper a baseline screen, so expert time goes to the inventions most worth protecting.
Publishing is the culture. Screening has to keep up with it.
Faculty are rewarded for publishing, and every paper, preprint, poster and talk is a public disclosure. Once it is out without a filing, rights in most countries outside the US are gone, and the US grace period starts running. Your office cannot review every manuscript before it goes out. Patenter can.
- →Screen every outgoing manuscript, preprint and abstract for inventive material
- →Flag the papers to fast-track for IP counsel review
- →Clear the rest quickly, so researchers are not held up
- →Turn flagged papers into evaluated disclosures in the same workflow
What one CU Anschutz paper left unprotected.
We screened a 2013 lung cancer paper from the University of Colorado Anschutz Medical Campus after it was published. 47 patents went on to cite it. Patenter found nine inventive features, two likely novel, and 14 elements no prior reference discloses.
Screen every internal disclosure for inventive material.
Triage internal disclosures with the same rigor whether you receive ten or a hundred, screen faculty papers and preprints for inventive material, and give PIs a way to explore and refine their ideas.
- →Advance, refine or reconsider each disclosure, with the evidence behind the recommendation
- →Upload a paper or preprint to identify inventive features
- →Invite PIs to explore and refine their inventive ideas
- →Provide organized materials ready for outside counsel review
Assess the risks and commercial potential of the patents you hold.
Know which applications and granted patents in your portfolio are worth licensing, worth spinning out or worth letting go, before you spend on prosecution, maintenance or a licensing conversation.
- →Identify where each patent is vulnerable to challenge
- →Assess commercial potential for each asset
- →Novelty and non-obviousness analysis against 5M+ prior art
- →Freedom-to-operate analysis with claim charts
- →Conservative and aggressive risk posture, per asset
One invention, start to finish.
Follow a disclosure through the interview, the first analysis, a refinement interview with targeted questions to close the gaps, a second analysis, and the final recommendation.
Free lost-IP assessment
See your capacity gap in your own numbers. We map your research-to-revenue funnel, compare your filing rate with your peers, and scan your publications for research that others patent on and your university never filed. You get a white paper that sizes the opportunity.
At a major public university in California, 1,250 papers were cited by third-party patents. 972 had no matching university filing.